Her primary areas of study are Endocannabinoid system, Cannabinoid, Cannabinoid receptor, Anandamide and Endocrinology. Her Endocannabinoid system research incorporates elements of Neuroscience, Fatty acid amide hydrolase and Pharmacology. The study incorporates disciplines such as Cannabidiol, Equilibrative nucleoside transporter 1, Equilibrative nucleoside transporter, Cell biology and Nucleoside transporter in addition to Cannabinoid.
Her Cannabinoid receptor study incorporates themes from Hypothermia and Enzyme-linked receptor. Her study on Anandamide also encompasses disciplines like
Cecilia J. Hillard mainly investigates Endocannabinoid system, Internal medicine, Endocrinology, Cannabinoid receptor and Cannabinoid. Her Endocannabinoid system research includes elements of Anandamide, Neuroscience, Fatty acid amide hydrolase and Pharmacology. In her work, Depression and Clinical psychology is strongly intertwined with Anxiety, which is a subfield of Internal medicine.
Her Prefrontal cortex research extends to the thematically linked field of Endocrinology. Her studies in Cannabinoid receptor integrate themes in fields like Central nervous system, Habituation and Ligand. Her Cannabinoid study combines topics from a wide range of disciplines, such as Agonist, Depolarization-induced suppression of inhibition, Cannabinoid Receptor Modulators and Cannabidiol.
Cecilia J. Hillard focuses on Endocannabinoid system, Internal medicine, Endocrinology, Cannabinoid receptor and Cannabinoid. Cecilia J. Hillard interconnects Posttraumatic stress, Psychiatry, 2-Arachidonoylglycerol, Anandamide and Fatty acid amide hydrolase in the investigation of issues within Endocannabinoid system. Her Internal medicine study combines topics in areas such as Oncology and Anxiety.
Her Endocrinology study incorporates themes from Extinction and URB597. Her biological study spans a wide range of topics, including Neuroscience, Immunology and Graft-versus-host disease. Her research integrates issues of Prefrontal cortex, AM251 and Ligand in her study of Cannabinoid.
Endocannabinoid system, Internal medicine, Endocrinology, Cannabinoid and Neuroscience are her primary areas of study. Her Endocannabinoid system study integrates concerns from other disciplines, such as Randomized controlled trial, 2-Arachidonoylglycerol, Mood, Anandamide and Fatty acid amide hydrolase. Her Internal medicine research incorporates themes from Extinction and Biomarker.
Her Endocrinology research integrates issues from Oleoylethanolamide, Analysis of variance and Treadmill. Cecilia J. Hillard has researched Cannabinoid in several fields, including Prefrontal cortex and AM251. Her Neuroscience research is multidisciplinary, incorporating elements of Blockade, Corticosterone, Postsynaptic potential and Cannabinoid receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains
Cristina Benito;Estefanía Núñez;Rosa M. Tolón;Erica J. Carrier.
The Journal of Neuroscience (2003)
Endocannabinoid Signaling Negatively Modulates Stress-Induced Activation of the Hypothalamic-Pituitary-Adrenal Axis
Sachin Patel;Craig T. Roelke;David J. Rademacher;William E. Cullinan.
Synthesis and Characterization of Potent and Selective Agonists of the Neuronal Cannabinoid Receptor (CB1)
Cecilia J. Hillard;Sukumar Manna;Marcie J. Greenberg;Ralph DiCamelli.
Journal of Pharmacology and Experimental Therapeutics (1999)
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
Katarzyna Maresz;Erica J. Carrier;Eugene D. Ponomarev;Cecilia J. Hillard.
Journal of Neurochemistry (2005)
Accumulation of N‐Arachidonoylethanolamine (Anandamide) into Cerebellar Granule Cells Occurs via Facilitated Diffusion
Cecilia J. Hillard;William S. Edgemond;Abbas Jarrahian;William B. Campbell.
Journal of Neurochemistry (2002)
Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
Sachin Patel;Cecilia J Hillard.
Journal of Pharmacology and Experimental Therapeutics (2006)
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
Erica J. Carrier;John A. Auchampach;Cecilia J. Hillard.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current
Debebe Gebremedhin;Andrew R. Lange;William B. Campbell;Cecilia J. Hillard.
American Journal of Physiology-heart and Circulatory Physiology (1999)
The mechanism of action of the Pseudomonas aeruginosa‐encoded type III cytotoxin, ExoU
Hiromi Sato;Dara W. Frank;Cecilia J. Hillard;Jimmy B. Feix.
The EMBO Journal (2003)
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.
Katarzyna Maresz;Gareth Pryce;Gareth Pryce;Eugene D Ponomarev;Giovanni Marsicano.
Nature Medicine (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: